Hazim S Ababneh (Hazim Ababneh)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Locally Advanced

Diffuse Large B Cell Lymphoma

Top Venues

Hematological oncology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Hazim S Ababneh, Andrea K Ng, Matthew J Frigault, Caron A Jacobson, Chirayu G Patel
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy. American journal of hematology (2024)
Hazim S Ababneh, Andrea K Ng, Matthew J Frigault, Caron A Jacobson, Chirayu G Patel
Radiotherapy as a bridging strategy for patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy. American journal of hematology 99 (9) (2024)
Hazim S Ababneh, Matthew J Frigault, Andrea K Ng, Chirayu G Patel
Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy. Hematological oncology (2023)
Hazim S Ababneh, Matthew J Frigault, Andrea K Ng, Chirayu G Patel
Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy. Hematological oncology 42 (1) (2023)
Hazim S Ababneh, Andrea K Ng, Jeremy S Abramson, Jacob D Soumerai, Ronald W Takvorian, Matthew J Frigault, Chirayu G Patel
Metabolic parameters predict survival and toxicity in chimeric antigen receptor T-cell therapy-treated relapsed/refractory large B-cell lymphoma. Hematological oncology (2023)
Hazim S Ababneh, Matthew J Frigault, Chirayu G Patel
Radiation therapy for patients with relapsed or refractory mantle cell lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy. Hematological oncology (2023)
Hazim S Ababneh, Matthew J Frigault, Andrea K Ng, Chirayu G Patel
Radiation therapy as bridging and salvage strategy among patients with secondary central nervous system lymphoma undergoing CD19-targeted chimeric antigen receptor T-cell therapy. Hematological oncology 42 (1) (2023)
Amal Al-Omari, Nedal Al-Rawashdeh, Rana Damsees, Khawlah Ammar, Ibrahim Alananzeh, Bayan Inserat, Dalia Al-Rimawi, Shrouq Tbayshat, Hazim S Ababneh, Haneen Alishreim, Hashem Abu Serhan, Faisal Al-Noaaimi, Hikmat Abdel-Razeq
Supportive Care Needs Assessment for Cancer Survivors at a Comprehensive Cancer Center in the Middle East: Mending the Gap. Cancers 14 (4) (2022)